Drug Type Small molecule drug |
Synonyms J 106366 |
Target |
Action antagonists |
Mechanism M3 receptor antagonists(Muscarinic acetylcholine receptor M3 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC25H40N2O2 |
InChIKeyUSXGOPZSRJTPET-CPJSRVTESA-N |
CAS Registry1044758-96-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pulmonary Disease, Chronic Obstructive | Preclinical | Japan | - |